| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.53 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |